Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ERNA
Final Refusal - Mailed
Show more
Class 5: Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namel…
Class 42: Testing, inspection, research, and development of pharmaceutical preparations for gene therapy
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 11 Nov 2025Application filedNew Application Entered
- 20 Mar 2026Assigned to an examining attorneyAssigned To Examiner
- 9 Apr 2026Office action issuedNon-Final Action Written
- 9 Jul 2026Response to office action filedTeas Response To Office Action Received
- 5 Aug 2026Final refusal issuedFinal Refusal Mailed
All 13 events
| 2026-08-05 | Final Refusal Mailed |
| 2026-08-05 | Final Refusal E-Mailed |
| 2026-08-05 | Notification Of Final Refusal Emailed |
| 2026-07-09 | Teas Response To Office Action Received |
| 2026-07-09 | Correspondence Received In Law Office |
| 2026-07-09 | Teas/Email Correspondence Entered |
| 2026-04-09 | Non-Final Action Written |
| 2026-04-09 | Non-Final Action E-Mailed |
| 2026-04-09 | Notification Of Non-Final Action E-Mailed |
| 2026-03-20 | Assigned To Examiner |
| 2026-02-12 | New Application Office Supplied Data Entered |
| 2025-11-11 | New Application Entered |
| 2025-11-11 | Application Filing Receipt Mailed |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namel…
Class 42 Technology & SaaS
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 5 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.